Skip to main content
Top
Published in: Clinical Rheumatology 4/2009

01-04-2009 | Brief Report

Hemophagocytic syndrome in elderly patients with underlying autoimmune diseases

Authors: Rie Tabata, Chiharu Tabata, Makoto Terada, Tomoko Nagai

Published in: Clinical Rheumatology | Issue 4/2009

Login to get access

Abstract

In patients with autoimmune disease-associated hemophagocytic syndrome (AAHS), the clinical features may differ from hemophagocytic syndrome (HPS) of other etiologies, and new criteria for AAHS have been proposed. Since bone marrow (BM) circumstances are changed according to aging, here we reviewed retrospectively our cases with AAHS in elderly patients, including two systemic lupus erythematosus (SLE), three Evans syndrome, one rheumatoid arthritis (RA), one Hashimoto thyroiditis, and one autoimmune pancreatitis. Although only two SLE patients were diagnosed as HPS by the classical criteria, the remaining patients except one RA met the criteria for AAHS. Seven patients except one SLE patient showed good response to therapy and demonstrated positive autoantibodies to blood cells, lower serum ferritin levels, and increased erythroblastic islands in the BM. We consider the diagnosis of AAHS should be carefully made when macrophages phagocytosing blood cells are observed in BM smear without hyperferritinemia in elderly patients with autoimmune diseases.
Literature
1.
go back to reference Kumakura S, Ishikura H, Kondo M, Murakawa Y, Masuda J, Kobayashi S (2004) Autoimmune-associated hemophagocytic syndrome. Mod Rheumatol 14:205–215PubMedCrossRef Kumakura S, Ishikura H, Kondo M, Murakawa Y, Masuda J, Kobayashi S (2004) Autoimmune-associated hemophagocytic syndrome. Mod Rheumatol 14:205–215PubMedCrossRef
2.
go back to reference Tabata R, Tabata C, Kita Y, Namiuchi S, Terada M, Nagai T (in press) Hemophagocytic syndrome in late-onset SLE patients (in Japanese). Jpn J Clin Immunol Tabata R, Tabata C, Kita Y, Namiuchi S, Terada M, Nagai T (in press) Hemophagocytic syndrome in late-onset SLE patients (in Japanese). Jpn J Clin Immunol
3.
go back to reference Risdall RJ, McKenna RW, Nesbit ME, Krivit W, Balfour HH Jr, Simmons RL et al (1979) Virus-associated hemophagocytic syndrome. A benign histiocytic proliferation distinct from malignant histiocytosis. Cancer 44:993–1002PubMedCrossRef Risdall RJ, McKenna RW, Nesbit ME, Krivit W, Balfour HH Jr, Simmons RL et al (1979) Virus-associated hemophagocytic syndrome. A benign histiocytic proliferation distinct from malignant histiocytosis. Cancer 44:993–1002PubMedCrossRef
4.
go back to reference Wong KF, Hui PK, Chan JK, Chan YW, Ha SY (1991) The acute lupus hemophagocytic syndrome. Ann Intern Med 114:387–390PubMed Wong KF, Hui PK, Chan JK, Chan YW, Ha SY (1991) The acute lupus hemophagocytic syndrome. Ann Intern Med 114:387–390PubMed
5.
go back to reference Henter JI, Elinder G, Ost A (1991) Diagnostic guidelines for hemophagocytic lymphohistiocytosis. The FHL Study Group of the Histiocyte Society. Semin Oncol 18:29–33PubMed Henter JI, Elinder G, Ost A (1991) Diagnostic guidelines for hemophagocytic lymphohistiocytosis. The FHL Study Group of the Histiocyte Society. Semin Oncol 18:29–33PubMed
6.
go back to reference Imashuku S (1997) Differential diagnosis of hemophagocytic syndrome: underlying disorders and selection of the most effective treatment. Int J Hematol 66:135–151PubMedCrossRef Imashuku S (1997) Differential diagnosis of hemophagocytic syndrome: underlying disorders and selection of the most effective treatment. Int J Hematol 66:135–151PubMedCrossRef
7.
8.
go back to reference Bessis MC, Breton-Gorius J (1962) Iron metabolism in the bone marrow as seen by electron microscopy: a critical review. Blood 19:635–663PubMed Bessis MC, Breton-Gorius J (1962) Iron metabolism in the bone marrow as seen by electron microscopy: a critical review. Blood 19:635–663PubMed
10.
go back to reference Kristiansen M, Graversen JH, Jacobsen C, Sonne O, Hoffman HJ, Law SK (2001) Identification of the haemoglobin scavenger receptor. Nature 409:198–201PubMedCrossRef Kristiansen M, Graversen JH, Jacobsen C, Sonne O, Hoffman HJ, Law SK (2001) Identification of the haemoglobin scavenger receptor. Nature 409:198–201PubMedCrossRef
11.
go back to reference Fabriek BO, Polfliet MM, Vloet RP, van der Schors RC, Ligtenberg AJ, Weaver LK (2007) The macrophage CD163 surface glycoprotein is an erythroblast adhesion receptor. Blood 109:5223–5229PubMedCrossRef Fabriek BO, Polfliet MM, Vloet RP, van der Schors RC, Ligtenberg AJ, Weaver LK (2007) The macrophage CD163 surface glycoprotein is an erythroblast adhesion receptor. Blood 109:5223–5229PubMedCrossRef
12.
go back to reference Esumi N, Ikushima S, Hibi H, Todo S, Imashuku S (1988) High serum ferritin level as a marker of malignant histiocytosis and virus-associated hemophagocytic syndrome. Cancer 61:2071–2076PubMedCrossRef Esumi N, Ikushima S, Hibi H, Todo S, Imashuku S (1988) High serum ferritin level as a marker of malignant histiocytosis and virus-associated hemophagocytic syndrome. Cancer 61:2071–2076PubMedCrossRef
13.
go back to reference Hamblin TJ (1996) Immunological abnormalities in myelodysplastic syndrome. Semin Hematol 33:150–162PubMed Hamblin TJ (1996) Immunological abnormalities in myelodysplastic syndrome. Semin Hematol 33:150–162PubMed
14.
go back to reference Voulgarelis M, Giannouli S, Ritis K, Tzioufas AG (2004) Myelodysplasia-associated autoimmunity: clinical and pathophysiologic concepts. Eur J Clin Invest 34:690–700PubMedCrossRef Voulgarelis M, Giannouli S, Ritis K, Tzioufas AG (2004) Myelodysplasia-associated autoimmunity: clinical and pathophysiologic concepts. Eur J Clin Invest 34:690–700PubMedCrossRef
Metadata
Title
Hemophagocytic syndrome in elderly patients with underlying autoimmune diseases
Authors
Rie Tabata
Chiharu Tabata
Makoto Terada
Tomoko Nagai
Publication date
01-04-2009
Publisher
Springer-Verlag
Published in
Clinical Rheumatology / Issue 4/2009
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-009-1086-2

Other articles of this Issue 4/2009

Clinical Rheumatology 4/2009 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.